OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-12-31-accounts

Charity Number: 1180844 CHARITABLE INCORPORATED ORGANISATION (CIO)

TISSUE VIABILITY SOCIETY (TVS) WORKING NAME: SOCIETY OF TISSUE VIABILITY

TRUSTEES' REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2021

NORTHOVER & CO ACCOUNTANTS LTD CHARTERED ACCOUNTANTS

132A BOURNEMOUTH ROAD CHANDLERS FORD, HAMPSHIRE SO53 3AL

TISSUE VIABILITY SOCIETY (TVS)

TABLE OF CONTENTS

Page 1 Legal & Administrative Information
Page 2 Independent Examiner's Report
Page 3 Income and Expenditure Account
Page 4 Comparative Income and Expenditure Account
Page 5 Balance Sheet
Pages 6 to 12 Notes to the Financial Statements
Appendix 1 Report of the Trustees

1.

TISSUE VIABILITY SOCIETY (TVS)

LEGAL AND ADMINISTRATIVE INFORMATION

Tissue Viability Society is an unincorporated entity and a registered charity governed by its memorandum and articles of association. The charity adopted a working name of Society of Tissue Viability, which was voted upon at the 2021 AGM and was formally adopted by the charity in February 2022. The legal name of the charity remains unchanged at this time.

CHARITY NUMBER 1180844 DATE OF REGISTRATION 26 November 2018

TRUSTEES
CHAIR Linda Primmer Until July 2021
Jeannie Donnelly From July 2021
VICE-CHAIR Jeannie Donnelly Until July 2021
Linda Primmer From July 2021
TREASURER Rachael Lee Resigned July 2021
Fran Norman From July 2021
DEUPTY TREASURER Fran Norman Until July 2021
Sarah Gardner From July 2021
OTHER TRUSTEES Tina Chambers Resigned July 2021
Ina Farrelly
Jemell Geraghty Resigned July 2021
Clare Greenwood Appointed July 2021
David Hibbitt
Natasha Levy
Liang Liu
Victoria Murray Appointed July 2021
Sharon Neill
Jane Nixon
Nikki Stubbs Resigned July 2021
Joanna Swan
Gill Sykes
Connie Traynor
Samantha Wharton Appointed July 2021
Kate Williams
PRINCIPAL ADDRESS Clinical Trials Research Unit
University of Leeds
Leeds
LS2 9JT
ACCOUNTANTS Northover & Co. Accountants Ltd
(Michael Northover TD FCA)
132A Bournemouth Road,
Chandlers Ford,
Hampshire
SO53 3AL
BANKERS Lloyds Bank PLC
15 Blackheath Village
London
SE3 9LH

TISSUE VIABILITY SOCIETY (TVS)

2.

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF TISSUE VIABILITY SOCIETY

I report on the accounts of the company for the year ended 31st December 2021 which are set out on pages 3 to 12.

RESPECTIVE RESPONSIBILITIES OF THE TRUSTEES AND EXAMINER

The trustees are responsible for the preparation of the accounts and they consider that an audit is not required for this year under section 144(2) of the Charities Act 2011 (the 2011 Act) and that an independent examination is permissible.

Having satisfied myself that the charity is not subject to an audit and is eligible for independent examination, it is my responsibility to:

examine the accounts under section 145 of the 2011 Act;

follow the procedures laid down in the general Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act; and

state whether particular matters have come to my attention.

BASIS OF INDEPENDENT EXAMINER’S REPORT

My examination was carried out in accordance with the general Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently no opinion is given as to whether the accounts present a "true and fair view" and the report is limited to those matters set out in the statement below.

INDEPENDENT EXAMINER’S STATEMENT

In connection with my examination, no matter has come to my attention:

to keep accounting records in accordance with section 386 of the Companies Act 2006; and

to prepare accounts which agree with the accounting records and comply with the accounting requirements of section 396 of the Companies act 2006 and with the methods and principles of the Statement of Recommended Practice: Accounting and Reporting by Charities

have not been met; or

to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to (2) be reached.

Michael Northover

…....................................................................................................

08/09/2022

Date…........................................................................................

M A Northover TD FCA on behalf of

NORTHOVER & CO ACCOUNTANTS LIMITED CHARTERED ACCOUNTANTS 132A BOURNEMOUTH ROAD CHANDLERS FORD, HAMPSHIRE

SO53 3AL

3.

TISSUE VIABILITY SOCIETY (TVS) STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST DECEMBER 2021

SUMMARY INCOME AND EXPENDITURE ACCOUNT

Notes
INCOMING RESOURCES
Incoming resources from generated funds
Project income
( 4 )
Subscriptions
Donations and legacies
( 6 )
Investment income
( 7 )
Other income
TOTAL INCOMING RESOURCES
RESOURCES EXPENDED
Project expenditure
( 4 )
Strategy/mission expenditure
( 8 )
Charitable activities
( 9 )
TOTAL EXPENDITURE
NET INCOMING RESOURCES
FOR THE YEAR BEFORE TRANSFERS
Transfers between funds
NET INCOME/(DEFICIT) FOR THE YEAR
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD		 Notes Restricted Unrestricted
As Restated
Funds
2021
2020
104,832
307,377
211,919
16,125
16,125
15,827
930
930
7,458
4
4
16
-
-
300
121,891
324,436
235,520
56,481
217,847
162,525
710
710
587
52,839
52,839
34,001
110,030
271,396
197,113
11,861
53,040
38,407
(4,000)
-
-
7,861
53,040
38,407
149,166
223,199
184,792
157,027
276,239
223,199
TOTAL FUNDS
Funds
202,545
-
-
-
-
202,545
161,366
-
-
161,366
41,179
4,000
45,179
74,033
119,212

The Income and Expenditure Account includes all gains and losses recognised in the year. All income and expenditure derives from continuing activities.

4.

TISSUE VIABILITY SOCIETY (TVS) STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST DECEMBER 2021

COMPARATIVE SUMMARY INCOME AND EXPENDITURE ACCOUNT

Notes
INCOMING RESOURCES
Incoming resources from generated funds
Project income
( 5 )
Subscriptions
Donations and legacies
( 6 )
Investment income
( 7 )
Other income
TOTAL INCOMING RESOURCES
RESOURCES EXPENDED
Project expenditure
( 5 )
Strategy/mission expenditure
( 8 )
Charitable activities
( 9 )
TOTAL EXPENDITURE
NET INCOMING RESOURCES
FOR THE YEAR BEFORE TRANSFERS
Transfers between funds
NET INCOME/(DEFICIT) FOR THE YEAR
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD		 Restricted
Funds
138,601
-
-
-
-
138,601
119,091
-
-
119,091
19,510
-
19,510
54,523
74,033		 Unrestricted
Funds
73,318
15,827
7,458
16
300
96,919
43,434
587
34,001
78,022
18,897
-
18,897
130,269
149,166		 TOTAL
FUNDS
As Restated
2020
211,919
15,827
7,458
16
300
235,520
162,525
587
34,001
197,113
38,407
-
38,407
184,792
223,199

5.

TISSUE VIABILITY SOCIETY (TVS) STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST DECEMBER 2021

CURRENT ASSETS
Debtors
Cash at bank and in hand
CREDITORS:
Amounts falling due within one year
NET CURRENT ASSETS
NET ASSETS
CAPITAL
Unrestricted funds
General fund
Restricted funds		 Notes
( 12 )
( 13 )
( 14 )
( 15 )		 2021
133,942
167,912
301,854
25,615
25,615
276,239
276,239
157,027
119,212
276,239		 As Restated
2020
112,746
133,337
246,083
22,884
22,884
223,199
223,199
149,166
74,033
223,199

The financial statements were approved by the board on

and signed on its behalf by:

………………………………………..................................... Jeannie Donnelly Chair

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2021

6.

1 ACCOUNTING POLICIES

1.11 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011.

Tissue Viability Society meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

1.12 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.

Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund are set out in the notes to the financial statements.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund.

1.13 Income

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

1.14 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

Governance costs are those incurred in connection with administration of the charity and compliance with constitutional and statutory requirements.

Costs of generating funds are costs incurred in attracting voluntary income, and those incurred in trading activities that raise funds.

1.15 Tangible fixed assets

The cost of tangible fixed assets, if any, is expended to the Income & Expenditure Account in the periods of acquisition.

Website design costs, if any, are written off in the year they are incurred.

1.16 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

1.17 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

1.18 Creditors

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2021

7.

1 ACCOUNTING POLICIES (cont.)

1.19 Financial instruments

The charity has elected to apply the provisions of Section 11 'Basic Financial Instruments' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Basic financial assets, which include debtors and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities, including creditors, are initially recognised at transaction price and are subsequently carried at amortised cost using the effective interest method. Financial liabilities classified as payable within one year are not amortised.

1.20 Taxation

The charity is exempt from corporation tax on its charitable activities.

1.21 Going concern

At the time of approving the financial statements and after considering various possible levels of impact of Covid-19, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the holding trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

2 TRUSTEES' RESPONSIBILITIES IN RESPECT OF THE FINANCIAL STATEMENTS

The law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial period which give a true and fair view of the charity’s financial activities during the year and of its financial position at the end of the year. In preparing financial statements giving a true and fair view, the trustees should follow best practice and:

•select suitable accounting policies and then apply them consistently;

•make judgements and estimates that are reasonable and prudent;

•state whether applicable accounting standards and statements of recommended practice have been followed, subject to any departures disclosed and explained in the financial statements;

•prepare the financial statements on the going concern basis unless it is inappropriate to presume that the society will continue in operation.

The trustees are responsible for keeping accounting records which disclose with reasonable accuracy the financial position of the society and which enable them to ascertain the financial position of the society and which enable them to ensure that the financial statements comply with applicable law. They are also responsible for safeguarding the assets of the society and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

3 RESERVES POLICY

The charity regulations require the society to define its policy in respect of reserves.

The trustees consider that as it no longer has full time employees with a permanent base, that it hold sufficient reserves to insure that it can continue its activities satisfactorily for a period of least 12 months even if its income was significantly reduced. However the Trustees do consider the Charity’s ongoing viability on an annual basis. Any funds and ongoing income not required for immediate needs is put on deposit to maximise interest and drawn upon as required.

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2021

8.

4 TOTAL PROJECT INCOME & EXPENDITURE

PROJECT INCOME & EXPENDITURE - UNRESTRICTED

2021
Income
Expenditure
Surplus/
(Deficit)
Journals
24,988
19,332
5,656
Education Programme Facilitator
-
1,383
(1,383)
Corporate Sponsors - 40% donation element
44,800
1,200
43,600
Educational Endorsements
14,200
6,792
7,408
Study Days
13,344
15,726
(2,382)
Webinars
7,000
6,850
150
WReN
500
5,198
(4,698)
104,832
56,481
48,351
PROJECT INCOME & EXPENDITURE - RESTRICTED
Income
Expenditure
Surplus/
(Deficit)
Educational Grants
59,100
-
59,100
TVS Conference
45,226
73,116
(27,890)
Legs Matter Project
71,289
66,733
4,556
Skin Care Champions
21,680
12,585
9,095
Stop the Pressure
5,250
8,932
(3,682)
202,545
161,366
41,179
TOTAL PROJECT INCOME & EXPENDITURE
Income
Expenditure
Surplus/
(Deficit)
307,377
217,847
89,530
5 TOTAL PROJECT INCOME & EXPENDITURE (COMPARATIVE)
PROJECT INCOME & EXPENDITURE - UNRESTRICTED (COMPARATIVE)
Income
Expenditure
Journals
20,166
16,251
Education Programme Facilitator
-
-
Corporate Sponsors - 40% donation element
35,300
-
Educational Endorsements
12,000
4,913
Study Days
5,552
4,870
Webinars
300
-
WReN
-
17,400
73,318
43,434		 2020
Surplus/
(Deficit)
3,915
-
35,300
7,087
682
300
-
47,284
Surplus/
(Deficit)
21,241
(6,416)
7,285
1,400
(4,000)
19,510
Surplus/
(Deficit)
66,794
2020
Surplus/
(Deficit)
3,915
-
35,300
7,087
682
300
(17,400)
29,884

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2021

9.

5 TOTAL PROJECT INCOME & EXPENDITURE (COMPARATIVE) (CONT.)

PROJECT INCOME & EXPENDITURE - RESTRICTED (COMPARATIVE)

Income
Expenditure
Educational Grants
53,048
31,807
TVS Conference
3,370
9,786
Legs Matter Project
72,133
64,848
Skin Care Champions
1,400
-
Stop the Pressure
5,650
9,650
WReN
3,000
3,000
138,601
119,091
TOTAL PROJECT INCOME & EXPENDITURE (COMPARATIVE)
Income
Expenditure
211,919
162,525
6 DONATIONS AND LEGACIES
2021
Donations
930
7 INVESTMENT INCOME
2021
Interest receivable
4
8 STRATEGY/MISSION EXPENSES
2021
EPUAP
-
Other conferences
710
710
9 CHARITABLE EXPENDITURE - UNRESTRICTED
2021
SUPPORT COSTS
Marketing, website and rebranding costs
28,908
Administration assistant
17,124
Council expenses - trustees fees
-
Printing, postage and stationery
53
Paypal charges
150
Bank charges
86
Just Giving charges
22
Insurance
1,163
Subscriptions
346
Training
-
Meeting expenses
266
Sundry expenses
427
48,545		 Surplus/
(Deficit)
21,241
(6,416)
7,285
1,400
(4,000)
-
19,510
Surplus/
(Deficit)
49,394
2020
7,458
2020
16
2020
367
220
587
2020
11,283
16,871
250
43
134
21
202
946
328
400
-
209
30,687

10.

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2021

9 CHARITABLE EXPENDITURE - UNRESTRICTED (CONT.)
GOVERNANCE COSTS
Independent examination
Council expenses
TOTAL CHARITABLE EXPENDITURE
10 STAFF COSTS
The average number of staff employed during the year was 0 (2020: 0).
There were no employees whose annual remuneration was £60,000 or more.		 2021
4,294
-
4,294
52,839		 2020
1,900
1,414
3,314
34,001

11 TRUSTEES REMUNERATION AND EXPENSES

During the year, amounts were paid/reimbursed to the trustees of the charity as follows:
2021
2020
Speaker fees
950
250
Educational endorsement fees
908
-
Travel expenses
366
1,414
2,224
1,664
Speaker fees were paid to a Trustee for preparation and speaking at Foundation Study Days.
Education endorsement fees were paid to 2 Trustees for review work undertaken on educational materials as part of
the Educational Endorsement offering.

No remuneration was paid to any Trustees during the year.

12 DEBTORS

Trade debtors
Amounts due from Pink@Pink TVS Ltd
Prepayments and accrued income
13 CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Trade creditors
Accruals and deferred income
14 UNRESTRICTED FUNDS
Funds
B/Fwd
Income
General funds
149,166
121,891
149,166
121,891		 2021
2020
24,988
23,866
107,965
87,934
989
946
133,942
112,746
2021
2020
1,441
21,218
24,174
1,666
25,615
22,884
Funds
Expenditure Transfers
C/Fwd
(110,030)
(4,000)
157,027
(110,030)
(4,000)
157,027

11.

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2021

15 RESTRICTED FUNDS
Educational Grants
TVS Conference
Legs Matter
Skin Care Champions
STOP the Pressure		 Funds
Funds
B/Fwd
Income
Expenditure
Transfers
C/Fwd
64,092
59,100
-
(65,012)
58,180
(5,666)
45,226
(73,116)
65,012
31,456
18,066
71,289
(66,733)
-
22,622
1,540
21,680
(12,585)
-
10,635
(4,000)
5,250
(8,932)
4,000
(3,682)
74,033
202,545
(161,366)
4,000
119,212

Educational Grants

The charity receives sponsorship through direct sponsorship or through our tiered corporate membership system to provide grants to healthcare professionals to enable them to attend the TVS conferences and exhibitions. The healthcare professionals will receive a grant to cover travel and accommodation costs for the event, as well as covering the cost of attending the events.

TVS Conference

The charity holds an annual conference covering a wide range of topics within the remit of the charity to enhance the knowledge and awareness of these topics for healthcare professionals across the country. The charity receives sponsorship and grants to enable this conference to be held.

Legs Matter

Legs Matter is a coalition of organisations working together to increase awareness, understanding and action on lower leg and foot conditions among the public and healthcare professionals through year-round activities and communications.

Skin Care Champions

Skin Care Champions provides people working in care homes and home care agencies a trusted programme of cost-effective and easily accessible education and support skin health and wound healing.

STOP the Pressure

Stop The Pressure aims to create a significant culture shift and eliminate avoidable pressure ulcers in acute, community and mental health provider settings through a variety of activities to support healthcare professional, including hosting free webinars with expert speakers leading informative sessions, putting together training sessions for organisations, producing grab packs and developing graphics and posters which can be adapted locally.

16 ANALYSIS OF NET ASSETS BETWEEN FUNDS

As at 31 December 2021
Debtors
Bank and Cash
Creditors
As at 31 December 2020
Debtors
Bank and Cash
Creditors		 Unrestricted
Restricted
2021
25,977
107,965
133,942
156,665
11,247
167,912
(25,615)
-
(25,615)
157,027
119,212
276,239
Unrestricted
Restricted
2020
24,812
87,934
112,746
147,238
(13,901)
133,337
(22,884)
-
(22,884)
149,166
74,033
223,199

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2021

12.

17 RELATED PARTIES

Pink@Pink TVS Ltd is a company registered in England and Wales (Company Number: 08199801) which acts on behalf on Tissue Viability Society in the organisation and management of several of the charity's funds and events. The company is currently owned and managed by individuals whom are not trustees of the charity. The charity maintains oversight of the financial dealings of the company through regular management reporting by the company to the charity.

Listed below is an overall summary of the transactions which have been undertaken on behalf of the charity.

2021 2020
Income 266,392 185,286
Expenditure 246,361 158,786
Amounts due from Pink@Pink TVS Ltd - Disclosed within Debtors 107,965 87,934

18 PRIOR YEAR ADJUSTMENTS

It had been identified during the course of the preparation of the current financial statements that income and expenditure which had been transacted on behalf of the charity by Pink@Pink TVS Ltd had been omitted from the financial statements of the charity.

In the comparative 2020 financial statements, the overall income has been uplifted by £185,286 and the overall expenditure has been uplifted by £158,786. A debtor has also been recognised within the financial statements of £87,934, representing the balance of funds which were held by the company on behalf of the charity at the Balance Sheet date. Amounts which were paid to/from the company by the charity have then been stripped out of the comparative accounts accordingly.

The opening position of funds for the comparative accounts has been uplifted by £61,435 from £123,357 to £184,792. The resultant effect of these changes has been an uplift in the Surplus for the year of £30,499 from £7,908 to £38,407 and an uplift to the Total Funds Carried Forward for the charity of £91,934, from £131,265 to £223,199.

Additionally, it has also been identified that some restricted funding had not been accounted for separately from the General Funds of the charity, along with the restricted funding which had been identified from the Pink@Pink TVS Ltd transactions mentioned above. Therefore, a balance of restricted funding of £55,888 was identified as the beginning of the comparative period, and £79,778 was identified as the balance at the end of the comparative period and thus has been disclosed separately.

The notes to the accounts and the Comparative Summary Income and Expenditure Account reflect the income and expenses which have been designated as relating to restricted funding.

The primary statements and the notes to the accounts have been updated to reflect the amendments identified above.

Trustees' Annual Report for theperiod Trustees' Annual Report for theperiod Trustees' Annual Report for theperiod Trustees' Annual Report for theperiod
From Period start date To Period end date
1st
January 2021		 31st
December
2021
Section A Reference and administration details
Charity name
Registered charity number
Charity's principal address
Tissue Viability Society (TVS)
known as Society of Tissue Viability
1180844
c/o The Clinical Trials Research Unit, University of Leeds,
Leeds LS2 9JT

Names of the charity trustees who manage the charity. Trustees are elected by the council or members.

----- Start of picture text -----
Trustee name Office (if any) Dates acted if not for whole year
1. Jeannie Donnelly Chair Since 2020, Chair since July 2021
2. Linda Primmer Vice Chair Since 2018
3. Frances Spratt Treasurer from July Since 2018
4. Rachael Lee Treasurer up to July Since 2019, resigned July 2021
5. Tina Chambers Conference lead & Since 2018, resigned July 2021
Regional Study Day lead
6. Ina Farrelly Since 2019
7. Sarah Gardner Vice Treasurer, Legs Since 2018
Matter lead
8. Jemell Geraghty Since 2018, resigned July 2021
9. Clare Greenwood Since 2021
10. David Hibbitt Industry representative Since 2018
11. Natasha Levy Since 2020
12. Liang Liu Since 2019
13. Victoria Murray Industry representative Since 2021
14. Sharon Neill Since 2020
15. Jane Nixon Since October 2020, re-elected July 2021
16. Nikki Stubbs Since 2018, resigned July 2021
17. Joanna Swan Since 2018
18. Gill Sykes Since 2018
19. Connie Traynor Since 2018
20. Samantha Wharton Since 2021
21. Kate Williams Since 2018
----- End of picture text -----

Society of Tissue Viability Annual Report

1

June 2022

Section B Structure, governance and management

Description of the charity’s trusts

Type of governing Constitution document How the charity is A Council of Trustees constituted Trustee selection methods Appointed by Council or elected by membership depending upon number of available places and number of applicants.

Section C Objectives and activities
Summary of the objects of
the charity set out in its
governing document
Summary of the main
activities undertaken for
the public benefit in
relation to these objects		 The objectives for which the Society is established are to promote
learning and advance public education in the study of tissue viability and
do all such things as may be conducive to improve standards in tissue
viability as a multi-professional activity.
All Trustees are aware of the public benefit guidance issued by the
Charity Commission and have had regard to this when making decisions
to undertake activities.
For the Society, the start of 2021 had a familiar ring to it, with another
lock down announced and NHS Trusts going back into emergency
measures. This time however, Trustees were now also involved with
rolling out the Government’s mass vaccination programme. With tougher
restrictions for Scotland, the annual conference due to take place in
Glasgow seemed to be in jeopardy. The Society’s reformed Crisis Group
quickly recommended to the Council that a face-to-face conference be
postponed until 2022 and that the 2021 conference be transformed into
an online event for the very first time. As an indication that such a
conference was viable, newly instituted virtual study days had already
shown that an online conference could prove extremely popular and may
attract an audience from around the world.
The re-formed Crisis Group again met weekly to manage the Society’s
core aims and activities until April 2021, when responsibility was handed
back to the full Council and its working groups. One key project for 2021
was a radical overhaul of how the Society presented itself, with a
refreshed brand placing the emphasis on the word ‘Society’ reinforcing
the idea that wound care relies on the combined activity of a wide group
of professionals. This was in part prompted by a perception that the
charity’s original name, Tissue Viability Society (TVS), led many to
believe it was an organisation for Tissue Viability Nurses only and not
representative of the team of professionals that effective wound care
requires. The rebranding process had begun in 2020 and continued
throughout 2021, with our new brand and working name, Society of
Tissue Viability, being launched in February 2022.
The objectives for which the Society is established are to promote
learning and advance public education in the study of tissue viability and
do all such things as may be conducive to improve standards in tissue
viability as a multi-professional activity.
All Trustees are aware of the public benefit guidance issued by the
Charity Commission and have had regard to this when making decisions
to undertake activities.
For the Society, the start of 2021 had a familiar ring to it, with another
lock down announced and NHS Trusts going back into emergency
measures. This time however, Trustees were now also involved with
rolling out the Government’s mass vaccination programme. With tougher
restrictions for Scotland, the annual conference due to take place in
Glasgow seemed to be in jeopardy. The Society’s reformed Crisis Group
quickly recommended to the Council that a face-to-face conference be
postponed until 2022 and that the 2021 conference be transformed into
an online event for the very first time. As an indication that such a
conference was viable, newly instituted virtual study days had already
shown that an online conference could prove extremely popular and may
attract an audience from around the world.
The re-formed Crisis Group again met weekly to manage the Society’s
core aims and activities until April 2021, when responsibility was handed
back to the full Council and its working groups. One key project for 2021
was a radical overhaul of how the Society presented itself, with a
refreshed brand placing the emphasis on the word ‘Society’ reinforcing
the idea that wound care relies on the combined activity of a wide group
of professionals. This was in part prompted by a perception that the
charity’s original name, Tissue Viability Society (TVS), led many to
believe it was an organisation for Tissue Viability Nurses only and not
representative of the team of professionals that effective wound care
requires. The rebranding process had begun in 2020 and continued
throughout 2021, with our new brand and working name, Society of
Tissue Viability, being launched in February 2022.

Society of Tissue Viability Annual Report

2

June 2022

All the Society’s activities are designed to encourage the collaborative thinking and action needed to solve wound and skin challenges. This is evidenced by the Society’s fantastic Journal, its annual conference, a range of educational events and webinars as well as support for the Wounds Research Network (WReN), the new Skin Care Champions programme, and ground-breaking campaigns such as Legs Matter and Stop the Pressure. The Society supports like-minded national and international organisations and during 2021 the Society was proud to sign a memorandum of support with the International Skin Tear Advisory Panel and also develop a closer association with the Canadian organisation for Nurses Specialized in Wound, Ostomy and Continence. To help with the increasing amount of work involved in keeping projects on track, the Society appointed Heidi Sandoz to formally lead the Skin Care Champions programme, designed to support, develop and improve skin and wound care practice within care homes and home care agencies. In addition, Sarah Gardner was appointed to facilitate the Society’s programme of education, working closely with the Society’s Education Group to plan the scientific programme of our conference, our education events and future collaborative work. In 2021, the Society continued to work closely with its Industry partners, whose valuable sponsorship helps the Society to invest in its aims and work. It is a true partnership, with the Society’s initiative to formally endorse high-quality independent education from our industry partners, as well as not-for-profit organizations. The education the Society approves must meet strict quality standards, be evidence based, be free from product bias or promotion and be accessible to the general wound care community. Finally, in 2021 the Society put in place a plan to help retain the wealth of knowledge and experience of Trustees at the end of their terms of office. The Society set up a new group, our Alumni, which is open to all Trustees after they stand down. In 2022, this idea expanded into the Associate Forum, where our Alumni can meet with and offer advice and support to Trustees as well as active members of the Society who wish to get hands on experience of the Society’s work. Below is a short summary providing further detail of the activities the Society has undertaken in 2021 in support of its strategic objectives.

1. Membership

One of the Society’s prime strategic aims is to encourage all professionals working in skin health and wound healing to become members of the Society and to ensure that members engage in a diverse range of Society activities. Due to the pandemic, the Society was forced to change its main way of working, with all educational events, including the conference, moving on-line. This move, however, did prove popular with our membership since it made our events more accessible to timepoor professionals. Overall membership numbers rose from around 560 at the end of 2020 to 624 at the end of 2021. Also popular with members are the Society’s regular updates through its e-newsletters and social media posts which are specifically tailored to support health care professionals and the NHS.

Society of Tissue Viability Annual Report

3

June 2022

2. Conference

In 2021 the Society’s annual conference went virtual and whilst Trustees, speakers, industry partners and delegates had to brave an unfamiliar computer-generated conference hall and exhibition space, the outcome was very successful. The week-long event was an opportunity to provide a broader programme with more subjects and themes and a mixture of sessions, such as bitesize sessions, themed days, international speakers and company sponsored symposia. The outcome of this is a library of ondemand assets for members future use which we believe will be invaluable. Membership sign-ups increased in the run up to the conference and the Society’s social media following saw a dramatic increase too. Over 2,300 people registered for the conference, many of whom were actively connecting with the Society for the first time. Of those that registered, 1194 became site members and signed up for the full functionality of the conference website. Of those site members, 60% (716 people) watched on the live stream. Over the week, unique visitors went from over 800 on the Monday, to around 300 on the Friday. Site sessions went from 1600 on Monday to around 500 on Friday and 1,270 delegates gave permission for their data to be shared with exhibiting companies. Another first for the 2021 conference was the introduction of sponsored scientific symposia, something that the Society had previously been reluctant to do. Financially very successful, these sessions required careful management and stewardship to ensure they complied with the Society’s long-held views on impartiality.

3. Study Days

The way we all work has changed dramatically over the past two years including the way the Society delivers its education. Members can now get the latest skin health and wound healing knowledge from the comfort and convenience of their own laptop. The Society turned its face-to-face Foundation study days into virtual events, introducing an industry showcase feature using virtual breakout rooms. Feedback for the new online format from both delegates and industry representatives has been excellent.

In 2021, the Society’s Fundamental study day programme was modernised further by including separate sessions on lower limb ulceration. Nine virtual Fundamental study days were held, with 6 companies per event and 642 delegates attending. The Society also explored running a study day specifically for industry members (a request received via the Crisis Group) with the aim of enhancing knowledge to support practice.

Also in 2021 our new online Advanced study days were implemented, with full-day sessions on the Lower Limb and Foot Care, Wound Care for Children, and Infection and Surgical Wounds. Again there were 6 companies per event and 473 delegates attending.

To help the Society achieve its expanded education offering we advertised for an experienced clinical educator to facilitate, deliver and monitor our education and training programmes across the UK; in November 2021 current Trustee Sarah Gardner took up the post of Scientific and Education Programme facilitator.

Society of Tissue Viability Annual Report

June 2022

4

Webinars

The Society also produced a series of highly evaluated webinars in 2021. Eight webinars were held over the year, four of which were as part of STOP the Pressure week. Two webinars were sponsored by our industry partners: Smith & Nephew sponsored the webinar Service Redesign: Real-world evidence and partnership working; while Waterless Bathing: Benefits & Implementation Challenges was held in association with GAMA Healthcare. All webinars were viewable over Zoom, Facebook Live, the Society’s website and YouTube channel. Over 1,500 people viewed these events on the various channels and they are continuing to get views on the Society’s YouTube channel.

Skin Care Champions

The pandemic highlighted the essential role that carers play in the healthcare system and it also showed just how important it is that social care workers have the training and support they need to deliver good care. The Society created the Skin Care Champions programme to provide people working in care homes and home care agencies with trusted, cost-effective and easily accessible education that supports skin health and wound healing.

After winning the prestigious Urgo Foundation Award, in 2021 the Society launched its Skin Care Champions programme and network by running a pilot with 12 organisations taking part initially. The ambition was to create and empower a Skin Care Champion for every care home or agency that joined the programme – someone who can help to make sure that excellent care is provided to their clients and residents and be seen a source of information and knowledge for their peers.

Training is delivered online, making it convenient for participants and cost-effective for care homes and agencies. All the educational material is evidence based, free of any product bias or promotion, and of the highest quality. To run the programme, the Society employed Heidi Sandoz to be our Skin Care Champions Educator and members of the Programme get access to our educator’s clinical expertise, thoughts and ideas.

Out of the original pilot scheme, only one Champion went on to complete the course and was invited to talk about their experience at our 2022 conference in Glasgow. A second cohort of up to 50 organisations, some of which had been part of the pilot scheme, was launched in April 2022.

Education Endorsement

A core part of the Society’s mission is to make sure that the best new thinking and practice in skin health and wound healing reaches the people it needs to. Our offering of Education Endorsement is a part of fulfilling this. We are proud to work with our industry partners and other not-for-profit organisations to help bring more high-quality, independent education to people with an interest in skin health and wound healing. Over the last year we have endorsed over 20 educational modules, for 5 organisations with more in the pipeline for 2022.

Society of Tissue Viability Annual Report

June 2022

5

4. Project work / consultations

The Society is regularly approached by external organisations nationally to offer opinion or consultation on work they may be doing. Largely this kind of work is undertaken without consulting the membership, but we are always mindful that we represent our membership when we respond. Project work and consultations this year have included:

Society of Tissue Viability Annual Report

6

June 2022

5. Journal of Tissue Viability

The Society’s journal, the Journal of Tissue Viability (JTV), is a high quality, peer reviewed journal that has an international readership. It is free to members and available to purchase by non-subscribers.

The JTV again experienced an upward trend in submissions during 2021. The number of articles submitted to the journal was 248, a 12.5.% on 2020. This is a significant increase as it continued to build on the surge in submissions seen the previous year. As in 2020, this significant increase was most likely attributable to the pandemic that saw the focus among academics shift away from laboratory or clinical projects, to manuscript preparation and writing. Submissions in 2021 also showed a significant shift away from Europe to Asia and while the journal is dominated by submissions from Europe and Asia, its readership remains international and diverse with the journal being disseminated very broadly.

Society of Tissue Viability Annual Report

June 2022

7

The journal’s impact factor for 2020 (reported in 2021) was 2.932 with its CiteScore dropping back slightly to 3.1. CiteScore counts the citations received in a 4-year period to articles, reviews, conference papers, book chapters and data papers published in the same period and divides this by the number of publications published in those 4 years.

In 2021 the JTV’s ranking stood at 15/122 (Quartile 1) in the Nursing Category and 34/69 (Quartile 2) in the Dermatology Category. Online active accounts downloaded/viewed over 167,866 journal articles via ScienceDirect, plus another 9,162 full-text downloads on Clinical Key.

In July 2021 Professor Dan Bader informed the Trustees of his intention to step down as Editor in Chief of the JTV. The search for a new Editor began, with a call for interest being sent out towards the end of the year.

7. Wider public engagement and public benefit

The Society contracts Pink Marketing to support its wider administrative needs including conference organisation, involvement in strategy and projects and managing our digital presence. In 2021, Pink Marketing helped the number of corporate sponsors the Society can count on for financial support to grow to 21 industry partners.

Pink manage the Society’s social media accounts. By year end, followers of the Society’s Twitter account had increased to 5,988 (up by 14.5%) Facebook to 4,355 followers (up by 40.5%) and LinkedIn to 1,553 (up by 48.5%). The Society also had 187 followers on Instagram by the year end. In addition, at the end of 2021 there were over 3,300 people subscribed to receive the Society’s informative e-newsletter.

During 2020 the COVID-19 pandemic provided an additional challenge to the already arduous task of wound care. As a matter of urgency, the Society created specific COVID-19 wound care area on its website to provide help and resources for clinicians and patients during the pandemic. The webpage was a true collaboration with the resources being constructed with permission from other associations and from partners in industry. For this and for the Society’s part in bringing together a group of industry and healthcare professionals in support of Stop the Pressure, the Society was recognised for its contribution to nursing and wound care in a pandemic and in February 2021 was presented with a special award by the Journal of Wound Care / World Union for Exceptional Services to Wound Care during a Pandemic.

Society of Tissue Viability Annual Report

8

June 2022

Section D Achievements and performance

Summary of the main achievements of the charity during the year

Society of Tissue Viability Annual Report

9

June 2022

Section D Achievements andperformance
week-long programme of webinars. The week of lunchtime
webinars was run in collaboration with the National Wound Care
Strategy Programme and our industry and media partners.

Wounds Research Network (WReN):a new contract secured
the Society’s financing for the network for another two years.

International Skin Tear Advisory Panel (ISTAP):new for 2021,
the Society formed a partnership with ISTAP to raise awareness
about the prevention and management of skin tears and skin
breakdown.

Journal of Tissue Viability: 2021 saw a continuing marked
upward trend in submissions first seen in 2020 and attributed to
changing work patterns during the pandemic. The JTV also saw a
rise in its Impact Factor and towards the end of the year the
search for a new Editor-in-Chief was begun.
Credit and thanks must go to the Society’s dedicated Trustees and all
those associated with our Council including Pink Marketing (Sue
Simmonds, Kerry Wiles and Dawn Rush) and administrator Charlotte
Hurdman, all of whom work consistently hard and passionately for the
charity. Not forgetting our enthusiastic members, partners in industry and
_Journal of Tissue Viability_without whom the Society would not be what it
is today. The Council of Trustees and Society of Tissue Viability is
comprised of people united in their passion for wound care and skin
health and drive to help solve the challenges of wound care as part of an
inter-disciplinary community.
Section E
 Financial review
Brief statement of the
charity’s policy on reserves
Details of any funds
materially in deficit
The Trustees are committed to maintaining financial reserves equivalent
to one year’s running costs.
The Society is not currently in deficit

Section F Other optional information

Section G

Declaration

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s)

Society of Tissue Viability Annual Report

10

June 2022

Full name(s)
Elizabeth Jean Donnelly		 Full name(s)
Elizabeth Jean Donnelly		 Full name(s)
Elizabeth Jean Donnelly
Position (e.g. Secretary,
Chair, etc.)
Chair of the Council of Trustees
Date 23/08/2022

Society of Tissue Viability Annual Report

11

June 2022